Composition for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
摘要
The present invention concerns combination of an amount of a GPR1 19 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-I level in a subject over that provided by the amount of the GPR1 19 agonist or the amount of the DPP-FV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-I level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-I secretagogues.
申请公布号
EP2322157(A1)
申请公布日期
2011.05.18
申请号
EP20100010659
申请日期
2006.01.09
申请人
ARENA PHARMACEUTICALS, INC.
发明人
CHU, ZHI-LIANG;LEONARD, JAMES, N.;AL-SHAMMA, HUSSIEN, A.;JONES, ROBERT, M.